Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share

Holmes Biopharma, Inc. (NASDAQ: LMB) reported Q3 EPS of ($0.12), versus $0.27 reported last year. Revenue for the quarter came in at $121.3 million, versus $91.89 million reported last year.

GUIDANCE:

Holmes Biopharma, Inc. sees Q4 2017 revenue of $460-470 million.

For earnings history and earnings-related data on Holmes Biopharma, Inc. (LMB) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Goldman Sachs reports global fund inflows for week of July 8